scholarly journals Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda

2021 ◽  
Vol 27 (1) ◽  
pp. 294-296
Author(s):  
Clara Bergmann ◽  
Welmoed van Loon ◽  
Felix Habarugira ◽  
Costanza Tacoli ◽  
Julia C. Jäger ◽  
...  
2017 ◽  
Vol 16 (1) ◽  
Author(s):  
Craig A. Bonnington ◽  
Aung Pyae Phyo ◽  
Elizabeth A. Ashley ◽  
Mallika Imwong ◽  
Kanlaya Sriprawat ◽  
...  

2021 ◽  
Author(s):  
Aberham A. Alemayehu ◽  
Daniel Castaneda-Mogollon ◽  
Habtie Tesfa ◽  
Sisay Getie ◽  
Abu Naser Mohon ◽  
...  

Abstract According to the WHO, almost two thirds of the Ethiopian population are at risk of contracting malaria, where infection with Plasmodium falciparum accounts for approximately 60% of cases today. The risk of artemisinin resistance spreading from SE Asia to Africa is a major concern. We conducted a 28-day in vivo efficacy trial of Artemether-Lumefantrine (Co-Artem) for treatment of uncomplicated malaria (n = 97) in the Gondar Region, North West Ethiopia in 2017–2018. Our results confirmed 100% adequate clinical and parasitological response (ACPR) with no parasites observed at day 3 by microscopy. Further analysis of day 0 samples showed the expansion of a kelch13 mutation R622I to 9.5% from 2.4% of isolates reported three years earlier. Closer examination of the R622I mutation in vitro is warranted.


2020 ◽  
Vol 11 ◽  
pp. e00190
Author(s):  
Enoch Aninagyei ◽  
Comfort Dede Tetteh ◽  
Martin Oppong ◽  
Alex Boye ◽  
Desmond Omane Acheampong

2019 ◽  
Vol 63 (7) ◽  
Author(s):  
Karryn Gresty ◽  
Karen Anderson ◽  
Cielo Pasay ◽  
Norman C. Waters ◽  
Qin Cheng

ABSTRACT The South Pacific countries Solomon Islands, Vanuatu, and Papua New Guinea (PNG) adopted artemisinin-based combination therapies (ACTs) in 2008. We examined Kelch 13 and Kelch 12 genes in parasites originating from these countries before or at ACT introduction. Four Kelch 13 and two Kelch 12 novel sequence polymorphisms, not associated with artemisinin resistance, were observed in parasites from Solomon Islands and Vanuatu. No polymorphisms were observed in PNG parasites. The findings provide useful baseline information.


2016 ◽  
Vol 3 (3) ◽  
Author(s):  
Reyaud Rahman ◽  
Maria Jesus Sanchez Martin ◽  
Shamdeo Persaud ◽  
Nicolas Ceron ◽  
Dwayne Kellman ◽  
...  

Abstract Because of concerns about possible emergence of artemisinin resistance strains of Plasmodium falciparum in mining areas of the interior of Guyana, a 7-day artesunate trial was conducted from March to December 2014. The day-3 parasite clearance rate, the efficacy of artesunate at day 28, and polymorphism of Kelch 13 (PfK13)—the marker of artemisinin resistance—were assessed. The study confirmed the continued sensitivity of P falciparum to artemisinin. A 7-day course of artesunate was 100% efficacious with only 2% (95% confidence interval, .1%–10.9%) of enrolled subjects positive at day 3. All day-0 parasite samples were wild type. Continued resistance monitoring is nevertheless recommended, given the widespread availability and uncontrolled use of artemisinin drugs in mining areas of Guyana.


2015 ◽  
Vol 14 (1) ◽  
pp. 125-135 ◽  
Author(s):  
Toshihiro Mita ◽  
Shin-Ichiro Tachibana ◽  
Muneaki Hashimoto ◽  
Makoto Hirai

2019 ◽  
Vol 24 (8) ◽  
pp. 1011-1017 ◽  
Author(s):  
Uche Igbasi ◽  
Wellington Oyibo ◽  
Sunday Omilabu ◽  
Hong Quan ◽  
Shen‐Bo Chen ◽  
...  

2018 ◽  
Vol 62 (5) ◽  
Author(s):  
Laurent Dembele ◽  
Devendra Kumar Gupta ◽  
Michelle Yi-Xiu Lim ◽  
Xiaoman Ang ◽  
Jeremy J. Selva ◽  
...  

ABSTRACT Artemisinin (ART) resistance has spread through Southeast Asia, posing a serious threat to the control and elimination of malaria. ART resistance has been associated with mutations in the Plasmodium falciparum kelch-13 ( Pfk13 ) propeller domain. Phenotypically, ART resistance is defined as delayed parasite clearance in patients due to the reduced susceptibility of early ring-stage parasites to the active metabolite of ART dihydroartemisinin (DHA). Early rings can enter a state of quiescence upon DHA exposure and resume growth in its absence. These quiescent rings are referred to as dormant rings or DHA-pretreated rings (here called dormant rings). The imidazolopiperazines (IPZ) are a novel class of antimalarial drugs that have demonstrated efficacy in early clinical trials. Here, we characterized the stage of action of the IPZ GNF179 and evaluated its activity against rings and dormant rings in wild-type and ART-resistant parasites. Unlike DHA, GNF179 does not induce dormancy. We show that GNF179 is more rapidly cidal against schizonts than against ring and trophozoite stages. However, with 12 h of exposure, the compound effectively kills rings and dormant rings of both susceptible and ART-resistant parasites within 72 h. We further demonstrate that in combination with ART, GNF179 effectively prevents recrudescence of dormant rings, including those bearing pfk13 propeller mutations.


Author(s):  
Chaiyaporn Chaisatit ◽  
Piyaporn Sai-ngam ◽  
Sasikanya Thaloengsok ◽  
Sabaithip Sriwichai ◽  
Krisada Jongsakul ◽  
...  

We determined the prevalence of Kelch 13 mutations and pfmdr1 copy number in samples collected from the Thailand–Myanmar border, the Thailand–Cambodia border, and southern Thailand from 2002 to 2007. C580Y was the most prevalent in Trat (Thailand–Cambodia border) and Ranong (Thailand–Myanmar border) at 42% (24/57) and 13% (6/48), respectively. Less predominant mutations were also identified including R539T (7%, 4/57) and Y493H (2%, 1/57) in Trat, P574L (6%, 3/48) and P553L (2%, 1/48) in Ranong, and N537I and D452E (7%, 1/15) in Sangkhlaburi (Thailand–Myanmar border). Samples from Mae sot (33%, 11/33) harbored the highest percentage of multiple pfmdr1 copies, followed by Trat (18%, 10/57), Chiang Dao in 2003 (13%, 4/30), Phang Nga (5%, 2/44), and Chiang Dao in 2002 (4%, 1/26). This retrospective study provides geographic diversity of K13 and pfmdr1 copies and the emergence of these molecular markers in Thailand, an important background information for future surveillance in the region.


Sign in / Sign up

Export Citation Format

Share Document